Autobacs Seven Co., Ltd. Fundamental Analysis (JPX: 9832.T)
Autobacs Seven Co., Ltd. Fundamental Analysis (JPX: 9832.T)
Autobacs Seven Co., Ltd. (JPX: 9832.T) shows moderate financial fundamentals with a PE ratio of 15.58, profit margin of 2.75%, and ROE of 5.78%. The company generates $284.7B in annual revenue with strong year-over-year growth of 12.24%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 47.1/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 9832.T's fundamental strength across five key dimensions:
Efficiency Score
Weak9832.T struggles to generate sufficient returns from assets.
Valuation Score
Excellent9832.T trades at attractive valuation levels.
Growth Score
Moderate9832.T shows steady but slowing expansion.
Financial Health Score
Excellent9832.T maintains a strong and stable balance sheet.
Profitability Score
Weak9832.T struggles to sustain strong margins.
Key Financial Metrics
Is 9832.T Expensive or Cheap?
P/E Ratio
9832.T trades at 15.58 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, 9832.T's PEG of -0.93 indicates potential undervaluation.
Price to Book
The market values Autobacs Seven Co., Ltd. at 0.90 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 5.10 times EBITDA. This is generally considered low.
How Well Does 9832.T Make Money?
Net Profit Margin
For every $100 in sales, Autobacs Seven Co., Ltd. keeps $2.75 as profit after all expenses.
Operating Margin
Core operations generate 4.72 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $5.78 in profit for every $100 of shareholder equity.
ROA
Autobacs Seven Co., Ltd. generates $3.32 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Autobacs Seven Co., Ltd. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Autobacs Seven Co., Ltd. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
9832.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
15.58
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.93
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.90
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.43
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.29
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.98
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.06
vs 25 benchmark
ROA
Return on assets percentage
0.03
vs 25 benchmark
ROCE
Return on capital employed
0.08
vs 25 benchmark
How 9832.T Stacks Against Its Sector Peers
| Metric | 9832.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 15.58 | 25.81 | Better (Cheaper) |
| ROE | 5.78% | 973.00% | Weak |
| Net Margin | 2.75% | -4892.00% (disorted) | Weak |
| Debt/Equity | 0.29 | 0.60 | Strong (Low Leverage) |
| Current Ratio | 1.98 | 2.32 | Neutral |
| ROA | 3.32% | 299.00% | Weak |
9832.T outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Autobacs Seven Co., Ltd.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
29.21%
Industry Style: Cyclical, Growth, Discretionary
High GrowthEPS CAGR
20.49%
Industry Style: Cyclical, Growth, Discretionary
High GrowthFCF CAGR
-13.57%
Industry Style: Cyclical, Growth, Discretionary
Declining